识别和验证circDOCK1/miR-138-5p/GRB7促进乳腺癌进展的轴
Yan Zhang1, Mei Yang1,2, Yiping Wang1
1Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, 510630, People's Republic of China.
Breast cancer (Dove Medical Press)
|December 4, 2024
概括
一种新的循环RNA,circDOCK1,通过调节circDOCK1/miR-138-5p/GRB7轴,促进HER2阳性乳腺癌的转移和进展. 这一发现为乳腺癌治疗提供了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 非编码RNA越来越多地被认为是它们在人类瘤中的作用.
- RNA相互作用网络对于乳腺癌的发展至关重要.
- 循环RNAs (circRNAs) 是一种新型的非编码RNAs类,具有新兴意义.
研究的目的:
- 为了确定涉及乳腺癌的新型循环RNA.
- 阐明这些循环RNAs的生物机制.
- 探索它们作为乳腺癌治疗点的潜力.
主要方法:
- HER2阳性乳腺癌组织和配对的正常组织的全转录组RNA测序.
- 差异表达的circRNAs,miRNAs和mRNAs的识别和网络构建.
- 生物信息分析,化酶测定和RIP测定用于验证.
- 定量逆转录PCR (qRT-PCR) 用于circDOCK1表达分析.
- 功能性救援实验,以评估circDOCK1/miR-138-5p/GRB7轴的作用.
主要成果:
- 鉴定了6960个差异表达的mRNA,133个miRNA和1691个circRNA.
- 丰富性分析表明它参与细胞分裂,细胞循环和DNA修复途径.
- 一个circDOCK1/miR-138-5p/GRB7竞争的内源RNA (ceRNA) 网络被构建和验证.
- 发现circDOCK1轴促进乳腺癌细胞迁移和入侵.
- 升高的circDOCK1表达与不良的临床病理特征和患者的不良结果相关.
结论:
- 一个新的circDOCK1/miR-138-5p/GRB7轴显著促进HER2阳性乳腺癌的转移和进展.
- CircDOCK1代表了乳腺癌治疗的潜在治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


